Parkinson's Disease Trial, By Invitation NCT07424508 Sponsor: Doris Wang, MD, PhD Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07424508
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are able to give their consent to take part in the study.
  • People who have already had a specific investigational deep brain stimulation (DBS) device called the Summit RC+S implanted.
  • People who do not have significant memory or thinking difficulties, shown by a score of 21 or higher on a standard cognitive test called the Montreal Cognitive Assessment (MoCA).
  • People who have signed a consent form agreeing to take part.
  • People aged between 21 and 75 years old.
  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's that developed on its own, not caused by another condition) and have had movement-related symptoms for 3 years or more.
  • People whose Parkinson's symptoms have not been adequately controlled despite trying appropriate oral (swallowed) medications, as assessed by a specialist in movement disorders.
  • People who meet one of the following movement-related criteria: their movement scores fall within a certain range when tested both on and off medication, and they experience at least 2 hours per day of good movement without troublesome involuntary movements; OR people whose Parkinson's is mainly characterised by tremor that has not responded to medication and causes significant difficulty with daily life despite the best available medication (confirm with trial site).
  • People who have walking difficulties such as slowed walking, shuffling steps, balance problems, or episodes of freezing (sudden inability to move the feet) when off medication.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are not able to follow the study procedures as required.
  • People who are unable to walk and use a wheelchair full time.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Doris Wang, MD, PhD
Registry
ClinicalTrials.gov
Start date
4 February 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Mini Balance Evaluation Systems Test (Mini-BESTest) Scores; Change in Gait; Change in Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III scores; Change in Stride Length; Change in Stride Time; Change in Double Support Time; Change in number of freezes; Change in number of falls; Change in Activities-Specific Balance Confidence (ABC) Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov